文献速递免疫规划传染病防控与疫情报告

奥地利蜱传脑炎:疾病负担与疫苗接种的影响(2000-2024年)

Tick-borne encephalitis: Burden of disease and impact of vaccination, Austria (2000-2024).
PubMed 文献 · Vaccine · 2025-10-12

该研究基于奥地利2000-2024年全国医院监测数据,回顾性分析实验室确诊的蜱传脑炎病例,估算不同接种状态人群的发病率与疫苗效果。结果显示,2260例住院病例中47%为重症、1.2%死亡;规律接种的保护效果达99%,不规律接种超过90%,期间预防了超过10000例住院、4000例重症和80例死亡。但疫苗覆盖与接种依从性随时间下降,未接种及不规律接种人群病例增加,导致蜱传脑炎发病率显著上升(p<0.0001)。

要点

  • 2260例住院蜱传脑炎病例中,重症占47%,死亡占1.2%。
  • 规律接种疫苗保护效果达99%,不规律接种超过90%。
  • 2000-2024年疫苗预防超过10000例住院、4000例重症和80例死亡。

核心结论

  • 蜱传脑炎疫苗接种在所有年龄组大幅降低疾病发病率。
  • 需要维持高疫苗覆盖率和遵守疫苗推荐以预防蜱传脑炎并减少医疗负担。

研究设计与样本

  • 研究为回顾性分析,使用奥地利2000-2024年全国医院监测数据,纳入实验室确诊的蜱传脑炎病例。
  • 按规律接种、不规律接种和未接种划分人群,计算年发病率,并基于接种与未接种组的发病率相对差异估算疫苗效果。
  • 估算2000-2024年疫苗接种预防的病例数,包括蜱传脑炎住院、重症和死亡。

主要发现

  • 2260例住院蜱传脑炎病例中,274例(12%)为儿童(1-15岁),1066例(47%)为成人(16-59岁),920例(41%)为老年人(≥60岁)。
  • 1051例(47%)记录为重症,26例(1.2%)死亡。
  • 疫苗保护效果:规律接种达99%,不规律接种超过90%。
  • 2000-2024年疫苗预防超过10000例住院、4000例重症和80例死亡。
  • 疫苗覆盖与接种依从性随时间下降,未接种及不规律接种人群病例增加,蜱传脑炎发病率显著上升(p<0.0001)。

关键数值与推荐

  • 规律接种蜱传脑炎疫苗的保护效果为99%。
  • 不规律接种蜱传脑炎疫苗的保护效果超过90%。

临床怎么用

  • 维持高疫苗覆盖率和遵守疫苗推荐以预防蜱传脑炎并减少医疗负担。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tick-borne encephalitis (TBE) incidence has increased across Europe in the past decade, even in Austria which has the highest vaccination coverage in Europe. This study investigated the field effectiveness of TBE vaccination using nationwide hospital-based surveillance data (2000-2024), and examined age-specific differences in vaccine effectiveness and disease severity. METHODS: We conducted a retrospective analysis of laboratory-confirmed TBE cases in Austria using nationwide hospital-based surveillance from 2000 to 2024. Annual TBE incidence rates were calculated for populations with regular, irregular, and no TBE vaccination. Vaccine effectiveness was estimated based on relative differences in incidence between vaccinated and non-vaccinated groups. Additionally, the number of cases prevented by vaccination from 2000 to 2024 was estimated, including TBE hospitalizations, severe cases, and deaths. RESULTS: Among 2260 hospitalized TBE cases, 274 (12 %) occurred in children (1-15 years), 1066 (47 %) in adults (16-59 years), and 920 (41 %) in older adults (≥ 60 years). Severe disease was documented in 1051 (47 %) patients, and 26 (1.2 %) patients died. TBE vaccination provided excellent protection (99 % with regular and > 90 % with irregular vaccination schedules) and prevented more than 10,000 hospitalizations, 4000 severe cases, and 80 deaths between 2000 and 2024. Our data, however, revealed that vaccine uptake and schedule adherence declined over time, coinciding with increasing case numbers in unvaccinated and irregularly vaccinated populations, which resulted in a significant rise in TBE incidence (p < 0.0001). CONCLUSIONS: TBE vaccination substantially reduced disease incidence across all age groups. Sustaining high vaccination coverage and compliance with vaccine recommendations is needed to prevent TBE and reduce healthcare burden.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Raffl S, Springer DN, Aberle SW, et al. Tick-borne encephalitis: Burden of disease and impact of vaccination, Austria (2000-2024). Vaccine. 2025. PMID: 41082815. doi:10.1016/j.vaccine.2025.127854

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。